Mature results from a randomized phase III trial of docetaxel/capecitabine (TX) vs. doxorubicin/cyclophosphamide (AC) as primary chemotherapy for patients (pts) with stage II/III breast cancer (BC).

被引：0

作者：

Lee, KS ^{[1
]}

Lee, ES ^{[1
]}

Kwon, YM ^{[1
]}

Nam, BH ^{[1
]}

Kwon, HS ^{[1
]}

Chung, KW ^{[1
]}

Kang, HS ^{[1
]}

Kim, EA ^{[1
]}

Kim, SW ^{[1
]}

Ro, J ^{[1
]}

机构：

[1] Natl Canc Ctr, Goyang, South Korea

来源：

BREAST CANCER RESEARCH AND TREATMENT | 2005年 / 94卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：S224 / S224

页数：1

共 50 条

[1] Interim analysis findings from a phase III randomized trial of docetaxel/capecitabine (TX) vs. doxorubicin/cyclophosphamide (AC) as primary chemotherapy for stage II/III breast cancer (BC)
Ahn, Joong-Bae
Oh, Jung-Hye
Kwon, Youngmee
Chung, Ki-Wook
Kang, Han-Sung
Shin, Kyung Hwan
Kim, Eun-A
Lee, Eun Sook
Ro, Jungsil
[J]. ANNALS OF ONCOLOGY, 2004, 15 : 57 - 57
[2] Docetaxel/capecitabine (TX) vs. doxorubicin/cyclophosphamide (AC) as primary chemotherapy for patients (pts) with stage II/III breast cancer (BC): interim analysis findings from a phase III randomised trial
不详
[J]. BREAST, 2005, 14 : S40 - S40
[3] Phase III randomized trial of primary chemotherapy with doxorubicin/cyclophosphamide (AC) vs docetaxel/capecitabine (TX) for stage II/III breast cancer (BC): Interim analysis.
Lee, HG
Lee, JJ
Jung, KH
Kwon, Y
Shin, EH
Chung, KW
Shin, KH
Kim, EA
Lee, ES
Ro, J
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 29S - 29S
[4] A randomized phase-III trial of docetaxel/capecitabine versus doxorubicin/cyclophosphamide as primary chemotherapy for patients with stage II/III breast cancer
Lee, Keun Seok
Ro, Jungsil
Nam, Byung-Ho
Lee, Eun Sook
Kwon, Youngmee
Kwon, Hye Soo
Chung, Ki Wook
Kang, Han Sung
Kim, Eun A.
Kim, Seok Won
Shin, Kyung Hwan
Kim, Seok-Ki
[J]. BREAST CANCER RESEARCH AND TREATMENT, 2008, 109 (03) : 481 - 489
[5] A randomized phase-III trial of docetaxel/capecitabine versus doxorubicin/cyclophosphamide as primary chemotherapy for patients with stage II/III breast cancer
Keun Seok Lee
Jungsil Ro
Byung-Ho Nam
Eun Sook Lee
Youngmee Kwon
Hye Soo Kwon
Ki Wook Chung
Han Sung Kang
Eun A Kim
Seok Won Kim
Kyung Hwan Shin
Seok-Ki Kim
[J]. Breast Cancer Research and Treatment, 2008, 109 : 481 - 489
[6] Phase-III trial of doxorubicin and docetaxel versus doxorubicin and cyclophosphamide for primary breast cancer
Mross, Klaus
[J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2006, 182 (04) : 253 - 254
[7] Docetaxel and doxorubicin compared with doxorubicin and cyclophosphamide as first-line chemotherapy for metastatic breast cancer: Results of a randomized, multicenter, phase III trial
Nabholtz, JM
Falkson, C
Campos, D
Szanto, J
Martin, M
Chan, S
Pienkowski, T
Zaluski, J
Pinter, T
Krzakowski, M
Vorobiof, D
Leonard, R
Kennedy, I
Azli, N
Murawsky, M
Riva, A
Pouillart, P
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (06) : 968 - 975
[8] Biweekly docetaxel and gemcitabine as neoadjuvant chemotherapy followed by adjuvant doxorubicin and cyclophosphamide therapy in stage II and III breast cancer patients:: results of a phase II study
Estevez, L. G.
Sanchez-Rovira, P.
Domine, M.
Leon, A.
Calvo, I.
Jaen, A.
Casado, V.
Rubio, G.
Diaz, M.
Miro, C.
Lobo, F.
Carrasco, E.
Casillas, M.
Antonio, B. San
[J]. CLINICAL & TRANSLATIONAL ONCOLOGY, 2007, 9 (05): : 317 - 322
[9] Anemia in stage II and III breast cancer patients treated with doxorubicin and cyclophosphamide (AC).
Kirshner, J
Hatch, M
Hennessy, DD
Tannous, RE
Fridman, M
Gupta, S
[J]. BLOOD, 2002, 100 (11) : 498B - 499B
[10] Biweekly docetaxel and gemcitabine as neoadjuvant chemotherapy followed by adjuvant doxorubicin and cyclophosphamide therapy in stage II and III breast cancer patients: results of a phase II study
L. G. Estévez
P. Sánchez-Rovira
M. Dómine
A. León
I. Calvo
A. Jaén
V. Casado
G. Rubio
M. Díaz
C. Miró
F. Lobo
E. Carrasco
M. Casillas
B. San Antonio
[J]. Clinical and Translational Oncology, 2007, 9 : 317 - 322

← 1 2 3 4 5 →